NL192987C - 11ß,21-Dihydroxy-3,20-dioxo-2'-methyl-5'H-pregna-1,4-dieno£17,16-d| oxazolinederivaten en preparaten die een dergelijk derivaat bevatten. - Google Patents
11ß,21-Dihydroxy-3,20-dioxo-2'-methyl-5'H-pregna-1,4-dieno£17,16-d| oxazolinederivaten en preparaten die een dergelijk derivaat bevatten. Download PDFInfo
- Publication number
- NL192987C NL192987C NL8102086A NL8102086A NL192987C NL 192987 C NL192987 C NL 192987C NL 8102086 A NL8102086 A NL 8102086A NL 8102086 A NL8102086 A NL 8102086A NL 192987 C NL192987 C NL 192987C
- Authority
- NL
- Netherlands
- Prior art keywords
- compounds
- hemisuccinate
- formula
- methyl
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0036—Nitrogen-containing hetero ring
- C07J71/0057—Nitrogen and oxygen
- C07J71/0068—Nitrogen and oxygen at position 16(17)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2167180 | 1980-04-28 | ||
IT21671/80A IT1141930B (it) | 1980-04-28 | 1980-04-28 | Esteri idrosolubili di steroido-ossazoli e loro composizioni farmaceutiche |
Publications (3)
Publication Number | Publication Date |
---|---|
NL8102086A NL8102086A (nl) | 1981-11-16 |
NL192987B NL192987B (nl) | 1998-03-02 |
NL192987C true NL192987C (nl) | 1998-07-03 |
Family
ID=11185149
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL8102086A NL192987C (nl) | 1980-04-28 | 1981-04-28 | 11ß,21-Dihydroxy-3,20-dioxo-2'-methyl-5'H-pregna-1,4-dieno£17,16-d| oxazolinederivaten en preparaten die een dergelijk derivaat bevatten. |
Country Status (9)
Country | Link |
---|---|
US (1) | US4440764A (fr) |
JP (1) | JPS5735600A (fr) |
BE (1) | BE888608A (fr) |
DE (1) | DE3116891A1 (fr) |
ES (1) | ES501697A0 (fr) |
FR (1) | FR2481279A1 (fr) |
GB (1) | GB2075511B (fr) |
IT (1) | IT1141930B (fr) |
NL (1) | NL192987C (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6439098A (en) * | 1987-08-04 | 1989-02-09 | Osaka Plant Eng Kk | Cleaning apparatus for multilayer interconnection board |
US4943579A (en) * | 1987-10-06 | 1990-07-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Water soluble prodrugs of camptothecin |
JPH07118583B2 (ja) * | 1993-06-11 | 1995-12-18 | 日本電気株式会社 | 非貫通スルーホールを有するプリント配線板およびその製造方法 |
ES2145507T3 (es) * | 1995-12-13 | 2000-07-01 | Lepetit Spa | Preparacion de (11beta,16beta)-21-(3-carboxi-3-oxopropoxi)-11-hidroxi-2'-metil-5'h-pregna-1,4-dieno(17,16-d)oxazol-3,20-diona. |
JP7430028B2 (ja) | 2017-01-17 | 2024-02-09 | 横浜ゴム株式会社 | パンク修理液収容容器 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2656366A (en) * | 1950-07-27 | 1953-10-20 | Merck & Co Inc | Water-soluble esters of cortisone and related compounds |
US3193459A (en) * | 1955-07-01 | 1965-07-06 | Upjohn Co | Steroid hemisuccinate compositions and method for extemporaneous administration |
NL128816C (fr) * | 1965-04-22 | |||
GB1119081A (en) * | 1966-01-11 | 1968-07-10 | Lepetit Spa | New steroids |
FR6615M (fr) * | 1966-01-11 | 1969-01-13 |
-
1980
- 1980-04-28 IT IT21671/80A patent/IT1141930B/it active
-
1981
- 1981-04-27 US US06/258,098 patent/US4440764A/en not_active Expired - Lifetime
- 1981-04-27 GB GB8112937A patent/GB2075511B/en not_active Expired
- 1981-04-28 BE BE0/204637A patent/BE888608A/fr not_active IP Right Cessation
- 1981-04-28 ES ES501697A patent/ES501697A0/es active Granted
- 1981-04-28 FR FR8108481A patent/FR2481279A1/fr active Granted
- 1981-04-28 JP JP6352881A patent/JPS5735600A/ja active Granted
- 1981-04-28 NL NL8102086A patent/NL192987C/nl not_active IP Right Cessation
- 1981-04-28 DE DE19813116891 patent/DE3116891A1/de active Granted
Also Published As
Publication number | Publication date |
---|---|
NL8102086A (nl) | 1981-11-16 |
GB2075511A (en) | 1981-11-18 |
US4440764A (en) | 1984-04-03 |
BE888608A (fr) | 1981-10-28 |
FR2481279B1 (fr) | 1984-01-06 |
JPS5735600A (en) | 1982-02-26 |
ES8203093A1 (es) | 1982-02-16 |
JPH0115519B2 (fr) | 1989-03-17 |
GB2075511B (en) | 1983-09-07 |
IT1141930B (it) | 1986-10-08 |
DE3116891C2 (fr) | 1992-07-16 |
ES501697A0 (es) | 1982-02-16 |
IT8021671A0 (it) | 1980-04-28 |
NL192987B (nl) | 1998-03-02 |
DE3116891A1 (de) | 1982-03-11 |
FR2481279A1 (fr) | 1981-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0033255B1 (fr) | Nouvelles oximes dérivées de l'érythromycine A, leur préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant | |
US3450693A (en) | Method of synthesizing adenosine,2',3'-o-isopropylidene-adenosine and intermediates thereof | |
KR100255524B1 (ko) | 탁산 유도체, 그의 제조방법 및 종양에 있어서의 용도 | |
US4472392A (en) | Sulfonate containing ester prodrugs of corticosteroids | |
IE45023B1 (en) | Androstadiene-17-carboxylic acids and their esters | |
CA1310009C (fr) | Promedicaments de type esters steroidiques | |
US4469689A (en) | Sulfonate containing ester prodrugs of corticosteroids | |
NL192987C (nl) | 11ß,21-Dihydroxy-3,20-dioxo-2'-methyl-5'H-pregna-1,4-dieno£17,16-d| oxazolinederivaten en preparaten die een dergelijk derivaat bevatten. | |
CA2871314A1 (fr) | Procede de preparation de steroides 17-substitues | |
Hosoda et al. | Convenient, high yield conversion of androst-5-ene-3. beta., 17. beta.-diol to dehydroisoandrosterone | |
JPS63501292A (ja) | テトラヒドロ脈管形成抑制ステロイド | |
DK165593B (da) | Fremgangsmaade til fremstilling af 6-methylen- delta4-3-ketosteroider | |
US3663579A (en) | Dimeric steroid-21-alkyl-carbonates and process for their manufacture | |
Jones et al. | 461. Basic derivatives of steroids. 3-Amino-7: 12-dihydroxy-and 3-amino-12-hydroxy-cholanic acid | |
EP0157567B1 (fr) | Esters carboxylés de pro-médicaments de corticostéroides | |
NL7906339A (nl) | Hydroxyalkaanzuurderivaten en werkwijzen voor het bereiden en toepassen van deze derivaten. | |
JPH0240648B2 (ja) | Ketsushobankatsuseiinshokuseizai | |
US3005836A (en) | Salts of steroidal amino acid esters | |
JPS6044319B2 (ja) | 新規なステロイド誘導体の製造法 | |
NL8203785A (nl) | Anthranilzuuresters. | |
Godefroi et al. | The dehydrative dimerization of 2-and 4-methyl-5-imidazolecarboxylic acids | |
CN117430653A (zh) | 一种氢化可的松醋酸酯的制备方法 | |
US3697510A (en) | Novel preparation of pregnanes | |
EP0444424B1 (fr) | Dérivés insaturés des acides biliaires, leur procédé de préparation et les compositions pharmaceutiques les renfermant | |
FI65263B (fi) | Foerfarande foer framstaellning av nya som progestativa och/eller ovulationshindrande medel anvaendbara 4,9-pregnadien-3,20-dionderivat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A85 | Still pending on 85-01-01 | ||
BA | A request for search or an international-type search has been filed | ||
BB | A search report has been drawn up | ||
BC | A request for examination has been filed | ||
V4 | Discontinued because of reaching the maximum lifetime of a patent |
Free format text: 20010428 |